- Class period: July 30, 2025 to February 24, 2026
- Lead plaintiff deadline: November 3, 2026
- Allegations: failure to disclose FDA Form 483 with over 18,000 complaints including life-threatening hypoglycemic events
- Allegations: misleading statements about remediation efforts and severity of FDA observations
- Law firm: The Law Offices of Frank R. Cruz
- A securities fraud class action lawsuit has been filed against Beta Bionics (BBNX). The complaint alleges the company made false and misleading statements between July 30, 2025 and February 24, 2026 regarding FDA safety issues with its iLet automated insulin delivery device. Specifically, the company allegedly failed to disclose an FDA Form 483 identifying over 18,000 complaints including life-threatening hypoglycemic events that were not properly investigated or reported. The company also allegedly misrepresented the scope and severity of FDA observations and the progress of remediation efforts.
The headline and the read are open. The reasons are one free account away, on every story.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
BORSAPLUSWhy it matters · Bull and bear case · Reaction against SPY and the sector · What to watch
Create a free account · no card